Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07454798 · ClinicalTrials.gov registry record · NA
A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT07454798: Recruiting NA study, sponsored by Children's Mercy Hospital Kansas City.
NCT07454798 is a NA study that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07454798, a NA study, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes. The main questions it aims to answer are: Is it feasible to enroll, randomize, and retain adolescents with migraine in this study? Do participants complete the VR sessions and study procedures as intended? Are there preliminary signals that the VR neurofeedback program may improve headache-related disability and symptoms? Researchers will compare Immersive Neurofeedback Self-Regulation Training (INSeRT), which uses brain activity recorded from a wearable electroencephalogram (EEG) headband to guide the VR experience, to a comparison VR program that presents immersive imagery without neurofeedback or guided relaxation training. Participants will: Complete a 4-week baseline period that includes headache logs, questionnaires, and a laboratory EEG assessment Be randomly assigned to one of two VR programs Complete VR sessions at home three times per week for 4 weeks Complete questionnaires at the end of treatment and again approximately 3 months later Repeat the laboratory EEG assessment at the end of treatment
Primary Outcome
Recruitment feasibility will be assessed by the number of participants screened and enrolled per month and the proportion of eligible participants who consent to participate.
Interventions
- BEHAVIORAL Immersive Neurofeedback Self-Regulation Training (INSeRT)
- BEHAVIORAL Virtual Reality Imagery (No Neurofeedback)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-05-13 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT07454798 shows while recruiting
NCT07454798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Immersive Neurofeedback Self-Regulation Training (INSeRT) is the first listed.
NCT07454798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07454798 about?
NCT07454798 is a clinical study titled "A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine". The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes. The main questions it aims to answer are: Is ...
What is the current status of trial NCT07454798?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-05-13. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07454798?
The interventions under investigation include: Immersive Neurofeedback Self-Regulation Training (INSeRT) (BEHAVIORAL), Virtual Reality Imagery (No Neurofeedback) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07454798?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07454798's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI